RESUMEN

The late follow-up results of combined and complex treatment of 305 patients, suffering cancer recti, were analyzed. After the operation in 250 (82%) patients the anticoagulants were administered, including the low-molecular-weight heparin (calcium nadroparine)--129 (42.3%), and nonfractionized heparin--in 121 (39.7%). In 55 (18%) patients the complex and combined treatment was conducted, according to the present standards, without application of anticoagulants. There was proved, that administration of calcium nadroparine in combined and complex treatment of patients, suffering cancer recti, had promoted the patients three-year and five-year survival indices increase due to reduction of the tumors generalization.

Asunto(s)

Anticoagulantes/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Heparina de Bajo-Peso-Molecular/uso terapéutico , Neoplasias del Recto/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Anticoagulantes/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Terapia Combinada , Supervivencia sin Enfermedad , Femenino , Heparina de Bajo-Peso-Molecular/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Neoplasias del Recto/mortalidad , Neoplasias del Recto/patología , Neoplasias del Recto/cirugía

Asunto(s)

Antineoplásicos/uso terapéutico , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/patología , Compuestos Organoplatinos/uso terapéutico , Humanos , Invasividad Neoplásica , Estadificación de Neoplasias , Oxaliplatino